Genome browser tracks of NFKB1 (TNFα pathway) and KDM2B (E2F target) highlight the differences in chromatin accessibility between NB patients and controls in the myeloid compartment (Fig. 5c). This evidence concerns the gene NFKB1 and neuroblastoma.